Senores Pharmaceuticals Limited has informed the Exchange regarding audio recordings of Earnings Conference Call for the quarter and financial year ended March 31, 2026.
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Senores Pharmaceuticals informed the exchanges that an Earnings Conference Call with analysts and institutional investors was held on May 14, 2026 to discuss the audited financial results for Q4 and FY ended March 31, 2026. The company has uploaded the audio recording on its investor relations website. The filing explicitly states that no Unpublished Price Sensitive Information (UPSI) was shared or discussed during the call, as required under SEBI regulations 30 and 46. This is a routine compliance disclosure with no specific numbers, guidance, or forward-looking statements included.
The filing is informational in nature with no direct impact on the stock. The explicit UPSI disclaimer is standard protective language and does not signal any new development.